Karlijn J. Nass

Novel classification for adverse events in GI endoscopy: the AGREE classification

Karlijn J. Nass, Liselotte W. Zwager, Manon van der Vlugt et al. · Gastrointestinal Endoscopy · 2021 · 259 citations · Full text

Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines

Giulia Martina Cavestro, Alessandro Mannucci, Francesc Balaguer et al. · Clinical Gastroenterology and Hepatology · 2022 · 106 citations · Full text

High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study

Karlijn J. Nass, Eline H. van den Berg, Klaas Nico Faber et al. · Metabolism · 2017 · 65 citations

Fatty Liver Disease, Obesity, Metabolic Syndrome +17

Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Evelien Dekker, Karlijn J. Nass, Marietta Iacucci et al. · Endoscopy · 2022 · 35 citations · Full text

Quality Improvement Initiative, Endoscopy, Ibd Colonoscopy +14

Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease

Karlijn J. Nass, Eline H. van den Berg, Eke G. Gruppen et al. · European Journal of Clinical Investigation · 2018 · 25 citations